News
News from us and our partners
News
News
Biovelocita
News
Crossover
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
CEO spotlight: Thierry Abribat's third straight win
Sofinnova’s newest partners discuss their career paths
Sofinnova publishes 2023 Impact Report
Johnson & Johnson to acquire Shockwave Medical
Cure51 raises €15 million to harness the power of cancer survivors
CEO spotlight: CinCor's Marc de Garidel
Tags
Topics
0 results
- News
Pi-Cardia’s ShortCut™ becomes First Leaflet Modification Technology to receive CMS NTAP for Valve-in-Valve TAVR
- News
Purespring Therapeutics receives UK CTA approval for Phase I/II clinical trial of PS-002 in patients with primary IgA nephropathy (IgAN)
- News
Nuage Therapeutics welcomes Olivier Corminboeuf and Blandine Guimet to their Leadership Team
- News
Abivax Announces Closing of $747.5 Million Public Offering
- News
TISSIUM announces U.S. commercial launch of COAPTIUM® Connect and strategic governance evolution
- News
Abivax Announces Positive Phase 3 Results from Both ABTECT 8-Week Induction Trials Investigating Obefazimod, its First-in-Class Oral miR-124 Enhancer, in Moderate to Severely Active Ulcerative Colitis
- News
Introducing Latent-X, a frontier generative AI model for protein binder design accessible via no-code platform for push-button protein design
- News
One Biosciences announces €15 Million Series A financing to advance clinical single cell profiling
- News
Moon Surgical Launches Maestro™ Platform at Lee Health
- News
AAVantgarde Receives FDA IND Clearance to Progress Stargardt Disease program AAVB-039
- News
Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension
- News
Micropep Technologies Appoints Georg Goeres as CEO to Lead Next Phase of Commercial Growth
- News
Bioptimus appoints Julie Gerardi as Chief Commercial Officer
- News
Purespring Therapeutics announce FDA IND clearance for Phase I/II clinical trial for primary IgA nephropathy (IgAN)
- News
World First: CorWave's Undulating Membrane Heart Pump Implanted in First Patient